Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000959151 | SCV001106040 | benign | MHC class II deficiency | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000959151 | SCV001462362 | benign | MHC class II deficiency | 2020-09-16 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003935907 | SCV004754631 | likely benign | CIITA-related disorder | 2019-06-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |